Related Experiment Video
Updated: Jul 11, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Current challenges in non-invasive insulin delivery systems: a comparative review
El-Sayed Khafagy1, Mariko Morishita, Yoshinori Onuki
1Department of Pharmaceutics, Hoshi University, Ebara 2-4-41, Shinagawa, Tokyo 142-8501, Japan.
Advanced Drug Delivery Reviews
|September 21, 2007
Summary
Researchers are developing needle-free insulin delivery methods to improve diabetes treatment. This review highlights advancements in non-invasive technologies for more convenient and effective insulin administration, moving beyond traditional injections.
Area of Science:
- Pharmaceutical Science
- Biotechnology
- Medical Devices
Background:
- Subcutaneous injections are the standard for insulin delivery in diabetes management.
- Existing methods face challenges with patient adherence and pharmacodynamic variability.
- Needle-free alternatives are sought to improve convenience and treatment efficacy.
Purpose of the Study:
- To review advancements in non-invasive insulin delivery technologies.
- To explore strategies overcoming biological barriers to insulin absorption.
- To highlight recent milestones in alternative insulin delivery systems.
Main Methods:
- Literature review of pharmaceutical research and technological developments.
- Analysis of strategies for bypassing gastrointestinal, mucosal, and skin barriers.
- Focus on innovations in the 21st century for insulin delivery.
Main Results:
- Various non-invasive approaches show promise in delivering insulin effectively.
- Technologies are being developed to overcome absorption barriers.
- Significant progress has been made in alternative insulin delivery systems.
Conclusions:
- Non-invasive insulin delivery holds significant potential for diabetes treatment.
- Continued research is crucial for refining these technologies.
- Alternative routes offer improved convenience and pharmacodynamics over injections.
Related Concept Videos
01:27Insulin Formulations: Types and Delivery
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into rapid-acting...
Short-acting insulins are divided into rapid-acting...
01:28Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices
Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...
01:19Modified-Release Drug Delivery Systems: Overview
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
01:27Drug Delivery Systems: Different Types
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
01:22Modified-Release Drug Delivery Systems: Rate-Programmed I
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
01:26Oral Drug Delivery Systems: Continuous-Release Systems
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...